Alkermes, Inc.
Clinical trials sponsored by Alkermes, Inc., explained in plain language.
-
New drug shows promise for controlling narcolepsy symptoms
Disease control CompletedThis study tested a new medication called ALKS 2680 for people with narcolepsy type 1. Researchers wanted to see if it could safely reduce daytime sleepiness and sudden muscle weakness (cataplexy) better than a placebo. The 92 participants took the drug or a placebo for 6 weeks w…
Phase: PHASE2 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New pill tested to fight narcolepsy sleepiness
Symptom relief CompletedThis study tested whether a new tablet called ALKS 2680 could safely reduce excessive daytime sleepiness in adults with narcolepsy type 2. Researchers compared the drug against placebo pills in 93 participants to see if it helped people stay awake longer and feel less sleepy. Par…
Phase: PHASE2 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC